« Back
Home /
Etoposide EP Impurity D

Etoposide EP Impurity D

Item no.	AXRE-AR-E02167-150mg
Manufacturer	Axios Research
CASRN	23363-35-1
Amount	150 mg
Quantity options	100 mg 150 mg 250 mg 50 mg
Specific against	other
Alias	(5R,5aR,8aR,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; Lignan P; (5R,5aR,8aR,9S)-9-(?-D-Glucopyranosyloxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-uro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; ?-D-4'-Demethylepipodophyllotoxin Glucopyranoside; 4-Demethylepipodophyllotoxin 7'-O-?-D-glucopyranoside; 4'-Demethylepipodophyllotoxin glucoside; Pptoxin II
Available
Manufacturer - Category	Impurities
Country of Origin	Canada
Molecular Weight	562.53
Manufacturer - Name	Etoposide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 150 mg

available

Delivery expected until 6/5/2025

Express Delivery: Save 1 days

Compare

Add to wishlist

Recommend by mail